Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Additional Human Albumin During Resuscitation in Patients With Surgical Septic Shock in Surgical Intensive Care Units: A Randomized Controlled Trial (The ALBumin Use in Surgical Septic Shock, ALBUS Study)

NCT07212582 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT07212582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07212582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Additional Human Albumin During Resuscitation in Patients With Surgical Septic Shock in Surgical Intensive Care Units: A Randomized Controlled Trial (The ALBumin Use in Surgical Septic Shock, ALBUS Study)
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 31, 2030
Enrollment
304 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, septic shock